FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical modelsCristina Corno, Paola Perego, Serena Stamatakos et al.|Biochemical Pharmacology|2017Cited by 44
Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastasesGiuliana Cassinelli, Cinzia Lanzi, Laura Dal Bo et al.|Cancer Letters|2017Cited by 29